Navigation Links
Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
Date:12/4/2008

(TORONTO: December 4, 2008) - An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.

Dr. Kelly Metcalfe, an associate professor at the University of Toronto's Lawrence S. Bloomberg Faculty of Nursing, and an adjunct scientist at Women's College Research Institute, led the nursing study, which was published online yesterday in the journal, Gynecologic Oncology.

"Although approximately 10% of women with ovarian cancer have a BRCA1 or BRCA2 mutation, the majority of women are not being referred for genetic testing. Women may not know they are eligible for free genetic testing and counseling, or health-care providers may not be making the referrals. This puts an entire family at risk because family members are unaware that they may also be at a very high risk of developing breast or ovarian cancer," says Metcalfe.

According to Metcalfe's study, lack of genetic testing referral for such women will miss more than one-third of those with BRCA1 and BRCA2 mutations. These mutations mean an 80% lifetime risk of breast cancer for these women and for family members who may also carry the gene.

The study also found women were more likely to get tested if they were:

  • White (20.6%)
  • Had children (21.3%)
  • And had a positive family history of breast cancer (47.2%) or ovarian cancer (55.2%), or personal history of breast cancer (62.1%)

In 2001, the Ontario Ministry of Health extended the criteria for genetic testing to include all women with a diagnosis of invasive ovarian or fallopian tube cancer because of the prevalence of the BRCA1 and BRCA2 gene mutations in these women. The purpose of the study was to assess the impact of this expanded policy for genetic testing in Ontario.

Generally, patients rely on physician referral for genetic testing. The study concludes reliance on physicians for patient referrals for genetic testing is inadequate and greater physician education and public awareness is needed.


'/>"/>

Contact: Lucianna Ciccocioppo
lucianna.ciccocioppo@utoronto.ca
416-946-3657
University of Toronto
Source:Eurekalert

Related medicine news :

1. U of T research supports Ontario ban on cigarette displays
2. Spinal cord research heads new $10M funding in London, Ontario
3. Marijuana use on the rise among Ontario adults, CAMH reports
4. HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778
5. HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056
6. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
7. HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sams Club in Richmond Hill, Ontario
8. 2007 Ottawa & Eastern Ontario Physique Championship to be Sponsored by Natural Nutrition
9. Women Unhappy With Disposal Options After Infertility Treatment
10. Financial Concerns Top List of Holiday Stressors for Women, Families with Children
11. PAHEF Works to Prevent Violence Against Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... Santa Rosa, CA (PRWEB) , ... July 23, 2017 , ... ... School of Medicine in St. Louis, and led by the Minneapolis Veterans Administration Health ... the early stages of the disease offers very few benefits. , In the ...
(Date:7/23/2017)... ... 23, 2017 , ... “I Am Not Nothin’: The Serpent Handler’s Daughter” is ... read and write and a brokenhearted young soldier who turned to whiskey after his ... about the power of simple faith is the work of published author Tommy G. ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... Augusta, GA (PRWEB) , ... July 21, 2017 , ... ... is teaming up with the Epilepsy Foundation in a community wide charity event with ... region. , Delaney Sunde, a young local woman who lives with epilepsy, recently launched ...
(Date:7/21/2017)... PHILADELPHIA (PRWEB) , ... July 21, 2017 , ... ... ARTZ Philadelphia and Theater of Witness , was awarded a $300,000 ... growing humanities program which fosters empathy, comfort with ambiguity and the recognition of ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017 The Institute for In Vitro ... the recipient of a VITROCELL® inhalation exposure system thanks ... Consortium. The device, which is designed to replace animals ... lung cells to airborne test materials in an environment ... VITROCELL® system for testing combustible tobacco products, as well ...
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
(Date:6/30/2017)... In vitro diagnostics market firm Kalorama Information ... least ten diagnostic companies have successfully completed financings.  The ... a loan facility.  The size of these financings ranged ... Information provides a monthly IVD Market Trends Report ... "Diagnostics deals ...
Breaking Medicine Technology: